Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PECS II and Parasternal Block for Analgesia in Mastectomy
NCT03754816Completed
- Sponsor
- San Salvatore Hospital of L'Aquila
- Start
- Dec 2018
- Primary completion
- Mar 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Open-label, single-arm trial of levobupivacaine in breast cancer, sponsored by San Salvatore Hospital of L'Aquila. Primary endpoint: Postoperative pain: Numeric Rate Scale. Started Dec 2018; status: completed.
02
Drugs
levobupivacaine
03
Conditions
breast cancer
Beyond the preview
Go deeper on NCT03754816.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03754816.